Protara Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protara Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q1 2024.
  • Protara Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $83K, a 7.79% increase year-over-year.
  • Protara Therapeutics, Inc. annual Depreciation for 2023 was $341K, a 37.5% increase from 2022.
  • Protara Therapeutics, Inc. annual Depreciation for 2022 was $248K, a 112% increase from 2021.
  • Protara Therapeutics, Inc. annual Depreciation for 2021 was $117K, a 13.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $83K +$6K +7.79% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $77K +$21K +37.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $56K +$24K +75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $32K -$18K -36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$108K $50K -$124K -71.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $16K -$279K -$311K -972% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $327K $100K +$78K +355% Jul 1, 2019 Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $249K $21K -$8K -27.6% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $257K $174K +$142K +444% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $115K $32K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $22K Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $29K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $32K -$8K -20% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $40K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.